Insider Transactions in Q2 2021 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.18%
|
$480,000
$96.18 P/Share
|
|
Jun 28
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.46%
|
$0
$0.46 P/Share
|
|
Jun 21
2021
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,950
+50.0%
|
-
|
|
Jun 21
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
1,001
-0.49%
|
$91,091
$91.41 P/Share
|
|
Jun 18
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
7,999
-1.31%
|
$727,909
$91.85 P/Share
|
|
Jun 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$630,000
$90.18 P/Share
|
|
Jun 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.76%
|
$450,000
$90.72 P/Share
|
|
Jun 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.42%
|
$0
$0.46 P/Share
|
|
Jun 04
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.66%
|
$2,460,000
$82.72 P/Share
|
|
May 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-3.17%
|
$435,000
$88.0 P/Share
|
|
May 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+8.46%
|
$0
$0.05 P/Share
|
|
May 27
2021
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+4.47%
|
-
|
|
May 27
2021
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+0.56%
|
-
|
|
May 27
2021
|
Donald B Milder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+1.21%
|
-
|
|
May 27
2021
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+0.26%
|
-
|
|
May 27
2021
|
Jonathan D Root Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+0.57%
|
-
|
|
May 27
2021
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+4.47%
|
-
|
|
May 27
2021
|
Kirk G. Nielsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,380
+2.65%
|
-
|
|
May 27
2021
|
Kirk G. Nielsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,982
+5.7%
|
-
|
|
May 25
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+16.92%
|
$0
$0.05 P/Share
|
|
May 20
2021
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+4.64%
|
$0
$0.43 P/Share
|
|
May 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.49%
|
$738,000
$82.58 P/Share
|
|
May 13
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Direct |
93,972
+15.26%
|
-
|
|
May 13
2021
|
Jonathan D Root Director |
SELL
Other acquisition or disposition
|
Indirect |
3,389,511
-100.0%
|
-
|
|
May 13
2021
|
Jonathan D Root Director |
BUY
Other acquisition or disposition
|
Indirect |
685,826
+50.0%
|
-
|
|
May 10
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.03%
|
$630,000
$90.72 P/Share
|
|
May 10
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.75%
|
$450,000
$90.49 P/Share
|
|
May 10
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.42%
|
$0
$0.46 P/Share
|
|
May 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.46%
|
$3,090,000
$103.62 P/Share
|
|
Apr 27
2021
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-5.84%
|
$565,000
$113.17 P/Share
|
|
Apr 27
2021
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+10.19%
|
$0
$0.05 P/Share
|
|
Apr 19
2021
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
9,000
-1.41%
|
$927,000
$103.26 P/Share
|
|
Apr 09
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.34%
|
$560,000
$112.45 P/Share
|
|
Apr 09
2021
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+6.42%
|
$0
$0.46 P/Share
|
|
Apr 09
2021
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$784,000
$112.45 P/Share
|
|
Apr 05
2021
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
150,000
-2.37%
|
$16,050,000
$107.96 P/Share
|
|
Apr 01
2021
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
252
-0.64%
|
$27,468
$109.21 P/Share
|
|
Apr 01
2021
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
360
-0.17%
|
$39,240
$109.21 P/Share
|
|
Apr 01
2021
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
253
-0.37%
|
$27,577
$109.21 P/Share
|
|
Apr 01
2021
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-0.04%
|
$50,031
$109.21 P/Share
|